Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Brain computer interface (BCI) is an emerging technology, which provides a direct communication between the brain and external device bypassing the normal neuromuscular pathways and helps in detecting and diagnosing various brain disorders such as epilepsy, brain tumors, as well as can restore the impaired motor functions.
The increasing prevalence of brain disorders, brain tumors, and disabilities due to stroke is expected to drive growth of the global brain computer interface market over the forecast period.
For instance, according to the study by Epilepsy Action Australia statistics in 2017, around 50 million people globally had epilepsy with around 80% of the people living in emerging economies such as India, Brazil, and China.
The global brain computer interface market is estimated to be valued at US$ 773.0 million in 2021 and is expected to exhibit a CAGR of 11.4% over the forecast period (2021-2028).
Figure 1. Global Brain Computer Interface Market Share (%) in Terms of Value, By Region, 2021
Increasing investment & funding to accelerate researches in the field of brain computer interface is expected to drive the market growth over the forecast period
Market players are focusing on various growth strategies such as investments and funding to accelerate researches in the field of brain computer interface, which is expected to boost growth of the global brain computer interface market over the forecast period.
For instance, in December 2020, researchers of Bioelectronics Laboratory of Department of Engineering, University of Cambridge received funding from the European Innovation Council (EIC) for their project MITICS – Mixed Ionic and electronic transport in conjugated polymers for bioelectronics, which is being carried out to develop microelectronics, in order to enhance signal quality of a new generation of less invasive brain-computer interfaces (BCIs).
Brain Computer Interface Market Report Coverage
||Market Size in 2021:
||US$ 773.0 Mn
|Historical Data for:
||2017 to 2020
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 1,649.9 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product: Invasive, Non-invasive, Semi-invasive
- By Application: Prevention, Detection and Diagnosis, Rehabilitation and Restoration
- By End User: Hospitals, Academic Institutes, Research Institutes
Neuralink Corporation, Neurable, Emotiv Inc., BitBrain, Alpha Omega, Blackrock Microsystems, LLC, Femtonics Ltd, NeuroNexus, Opto Circuits (India) Limited, BIOTRONIK, Plexon Inc., Noldus Information Technology, NextMind, Nectome, and Paradromics
- Increasing investment & funding to accelerate researches in the field of brain computer interface
- Increasing prevalence of brain disorder
|Restraints & Challenges:
- Challenges associated with brain computer interface
Figure 2. Global Brain Computer Interface Market Share (%), by Product, 2021
The increasing prevalence of brain tumors is another major factor, which is expected to drive the market growth. For instance, according to the National Brain Tumor Society, a non-profit organization in the U.S., around 84,170 cases of primary brain tumor are expected to be diagnosed in 2021 in the U.S., out of which around 59,040 tumors are estimated to be benign (non-malignant), while 25,130 will be malignant.
Global Brain Computer Interface Market – Impact of Coronavirus (Covid-19) Pandemic
The lockdown imposed in most of the countries has placed an economic burden on the private healthcare sector. Healthcare providers are facing challenges in terms of additional manpower, equipment, consumables, and other resources required to ensure safety in hospitals and to provide treatment to patients with other diseases.
Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products, and affected growth of healthcare businesses of various companies across the globe.
Considering the implication of social distancing measure, the footfall in clinics and health institutions has fallen by over 70% during this pandemic. Owing to this, the adoption of digital health services has increased by three-fold.
However, healthcare IT industry has witnessed paradigm shift in the adoption of healthcare IT solutions across the ecosystem including drug discovery, drug development, diagnostics, data management, marketing, and patient engagement. Artificial Intelligence, electronic health record (EHR), revenue cycle management, reimbursement data management, and clinical data management solutions are being rapidly adopted by companies, including Contract research organization (CROs), insurers, diagnostics, and research institutes for remote data monitoring.
Global Brain Computer Interface Market Restraint
Brain computer interfaces technology has proven to be useful for both medical as well as non-medical fields such as smart environment, games, safety, and others. However, there are several challenges associated with the technology, which can hinder the market growth in the near future. The challenges are summarized in the following categories:
Neuro-psycho-physiological issues: Brain is the most complex organ of human body. Hence, the genetic complexity and diversity of brain creates neurological challenges, while using the brain computer interfaces technology. Psychological challenges include parameters such as attention, fatigue, stress, and other emotions, which depend on individual personality.
Major players operating in the global brain computer interface market include Neuralink Corporation, Neurable, Emotiv Inc., BitBrain, Alpha Omega, Blackrock Microsystems, LLC, Femtonics Ltd, NeuroNexus, Opto Circuits (India) Limited, BIOTRONIK, Plexon Inc., Noldus Information Technology, NextMind, Nectome, and Paradromics